Abstract
There is a growing body of literature on the impact of COVID-19 nonpharmaceutical interventions (NPI) on other infectious diseases. [1-7] In their article published in The Lancet Regional Health – Western Pacific, Li-Ping Wang and colleagues [8] analyzed data from 134 hospitals across 27 provinces in China to evaluate the incidence of common acute diarrheal pathogens through four phases of COVID-19 NPI in 2020 compared to historical data. Their data was obtained from the Chinese Center for Disease Control and Prevention's nationwide surveillance program for acute diarrhoea, offering a lengthy (the program began in 2009) and detailed historical record of geographic and seasonal variations for comparison.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
